Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,159,872 papers from all fields of science
Search
Sign In
Create Free Account
rindopepimut
A cancer vaccine consisting of a human epidermal growth factor receptor variant III (EGFRvIIi)-specific peptide conjugated to the non-specific…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Narrower (3)
CDX-110
PF 04948568
SPX 110
Broader (2)
Cancer Vaccines
Vaccines, Subunit
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Trials in Glioblastoma — Designs and Challenges
Helen J Madsen
,
Justin E. Hellwinkel
,
M. Graner
2017
Corpus ID: 3634112
2016
2016
Abstract 580: Anti-EGFRvIII TandAbs recruiting either T or NK cells are highly specific and potent therapeutic antibody candidates for the treatment of EGFRvIII+ tumors
Kristina Ellwanger
,
U. Reusch
,
+4 authors
M. Treder
2016
Corpus ID: 78316579
EGFRvIII is the most prevalent tumor-specific variant of the wild-type EGFR and represents an attractive tumor target in various…
Expand
2015
2015
ReACT: Vaccine Improves Long-Term Survival in Recurrent EGFRvIII-Positive Glioblastoma
B. Furlow
2015
Corpus ID: 182550022
Adding rindopepimut to bevacizumab therapy was associated with improved long-term survival in patients with recurrent EGFRvIII…
Expand
2014
2014
Rindopepimut Vaccine With Bevacizumab Ups Survival in Recurrent Glioblastoma
D. Levitan
2014
Corpus ID: 165121168
The immunotherapeutic rindopepimut with bevacizumab yielded a significant survival improvement in relapsed glioblastoma patients…
Expand
2010
2010
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2010
Corpus ID: 43025264
(-)-Epigallocatechin gallate, Abafungin, ACE-031, Adapalene/benzoyl peroxide, AE-37, Aflibercept, AGS-003, Albiglutide…
Expand